Dashboard
Manage Tickers

ITOSiTeos Therapeutics, Inc.

Nasdaq iteostherapeutics.com


$ 17.55 $ -0.32 (-1.76 %)    

Thursday, 23-May-2024 15:59:24 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -7.36 (-1.6 %)
DIA $ 398.57 $ -6.54 (-1.65 %)
SPY $ 530.36 $ -7.23 (-1.36 %)
TLT $ 91.26 $ -0.67 (-0.73 %)
GLD $ 225.37 $ -3.45 (-1.57 %)
$ 17.86
$ 17.86
$ 17.50 x 100
$ 0.00 x 0
$ 17.42 - $ 17.92
$ 8.20 - $ 18.75
321,431
na
640.16M
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-24-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 09-01-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-iteos-therapeutics-raises-price-target-to-46
HC Wainwright & Co. Maintains Buy on ITeos...
05/13/2024 11:16:46

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ITeos Therapeutics (NASDAQ:ITOS) with a Buy and raises the ...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/10/2024 16:31:07

genpact-posts-upbeat-earnings-joins-groupon-natera-funko-cargurus-and-other-big-stocks-moving-higher-on-friday
Genpact Posts Upbeat Earnings, Joins Group...
05/10/2024 14:48:27

dow-jumps-over-100-points-dnow-posts-downbeat-earnings
Dow Jumps Over 100 Points; DNOW Posts Down...
05/10/2024 14:00:59

Core News & Articles
Market-Moving News for May 10th
05/10/2024 12:41:27

ITOS: 39% | iTeos Therapeutics shares are trading higher after the company announced a $120 million registered direct offering ...

iteos-therapeutics-expects-topline-data-from-phase-1-trial-in-2h-2024
ITeos Therapeutics Expects Topline Data Fr...
05/10/2024 12:29:03

iteos-therapeutics-announces-120m-registered-direct-offering-of-57m-shares-of-common-stock-at-a-price-of-17499share
Iteos Therapeutics Announces $120M Registe...
05/10/2024 12:27:41

iteos-therapeutics-q1-2024-gaap-eps-107-misses-102-estimate
ITeos Therapeutics Q1 2024 GAAP EPS $(1.07...
05/10/2024 12:27:39

ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of ...

reported-earlier-iteos-to-present-eos-984-preclinical-data-demonstrating-restoration-of-t-cell-activity-from-adenosine-suppression-at-aacr-2024
Reported Earlier, iTeos To Present EOS-984...
04/08/2024 06:26:00

jp-morgan-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-27
JP Morgan Maintains Overweight on ITeos Th...
03/12/2024 13:09:47

JP Morgan analyst Brian Cheng maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from ...

hc-wainwright--co-reiterates-buy-on-iteos-therapeutics-maintains-44-price-target
HC Wainwright & Co. Reiterates Buy on ITeo...
03/07/2024 12:27:39

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Buy and maintains ...

recap-iteos-therapeutics-q4-earnings
Recap: ITeos Therapeutics Q4 Earnings
03/06/2024 14:00:17

iteos-therapeutics-q4-eps-085-beats-103-estimate-cash-and-investment-position-of-6327m-is-expected-to-provide-cash-runway-through-2026
ITeos Therapeutics Q4 EPS $(0.85) Beats $(...
03/06/2024 12:26:50

ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(...

iteos-to-highlight-preclinical-data-on-first-in-class-eos-984-targeting-ent1-at-the-american-association-for-cancer-research-annual-meeting-2024
iTeos To Highlight Preclinical Data On Fir...
03/05/2024 21:36:32

iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of ...

iteos-announces-2024-strategic-priorities-and-anticipated-milestones-cash-balance-and-investment-balance-of-6449m-as-of-september-30-2023-expected-to-provide-runway-through-2026
iTeos Announces 2024 Strategic Priorities ...
01/08/2024 13:45:30

- TIGIT program clinical data readouts anticipated in 2024, including two Phase 2 trials assessing belrestotug + dostarlimab ...

jp-morgan-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-29
JP Morgan Maintains Overweight on ITeos Th...
11/13/2023 15:55:00

JP Morgan analyst Daniel Wolle maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from...

iteos-therapeutics-q3-eps-090-beats-120-estimate-cash-cash-equivalents-and-investments-position-was-6449m-expected-to-provide-runway-through-2026
ITeos Therapeutics Q3 EPS $(0.90) Beats $(...
11/07/2023 12:21:19

ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of $(...

wedbush-reiterates-outperform-on-iteos-therapeutics-maintains-33-price-target
Wedbush Reiterates Outperform on ITeos The...
10/18/2023 14:15:00

Wedbush analyst David Nierengarten reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Outperform and maintains $33 price tar...

why-servisfirst-bancshares-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why ServisFirst Bancshares Shares Are Trad...
10/17/2023 17:42:48

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION